Delivery Order SPE2DB22D3016-SPE2DB25FAJU6

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,114.84 and is a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of August 30, 2024. Amerisourcebergen holds significant Indefinite...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COSENTYX SENSOREADY 150 MG PENML medication. The award, valued at $7,493.34, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, through a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $10,924.27 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 14, 2025, with a completion date of February 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,332.36 delivery order contract is for the procurement of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 25, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The award, with a ceiling value of $8,480.89, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PEN ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $15,650.17 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. No set-aside was used for this award. The contract is...
This federal contract award, valued at $18,183.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of COSENTYX SENSOREADY 150 MG PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. This contract award is associated with a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML. The award has a ceiling value of $20,527.68 and an ultimate completion date of March 6, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,347.23, is for the delivery of COSENTYX SENSOREADY 150 MG Pens, a specialty pharmaceutical product. The contract has a completion date of February 7, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML pharmaceutical products. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $1,832.99. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJU6
    Delivery Order

This contract award is for delivery orders of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $11,460.04. The contract is a firm-fixed-price delivery order contract with an ultimate completion date of January 13, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors.

Generated 4/11/25, 11:30 AM